Headquartered in Brentwood, TN·Fiscal year ends December·NASDAQ: CYRX·cryoportinc.com
About Cryoport
Cryoport, Inc. provides integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine and cell and gene therapies (CGT). Its customers include biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers and researchers.
The company reports two segments:
- **Life Sciences Services** (about 57% of Q3 2026 revenue) includes BioLogistics Solutions and BioStorage/BioServices. These cover the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized logistics, storage, and cryopreservation services. Delivery runs through a Global Supply Chain Center Network, including Santa Ana, California and Paris, France, and through CRYOGENE.
- **Life Sciences Products** (about 43%) consists mainly of cryogenic systems sold by MVE Biological Solutions.
As of September 30, 2026, Cryoport supported 23 commercially approved cell and gene therapies and 788 clinical trials across the Americas, EMEA and APAC. It sold its CRYOPDP specialty courier business to DHL Group in June 2025, and that business is now reported as discontinued operations. Updated
Friday's top analyst upgrades and downgrades included Adobe, American Airlines, BorgWarner, Coherent, Freeport-McMoRan, SL Green Realty, Snowflake, Southwest Airlines, Wendy’s and Wolfspeed.
Friday's top analyst upgrades and downgrades included AppLovin, Crown Castle, GoodRx, Global Payments, Monster Beverage, Penn Entertainment, Plug Power, Roblox, Southern Company and Wynn Resorts.
Friday's top analyst upgrades and downgrades included Alibaba, Chewy, Danaher, Energy Transfer, LyondellBasell, LiveNation, Salesforce, Seagate, Splunk and Textron.
Monday's top analyst upgrades and downgrades included Abercrombie & Fitch, Cabot Oil, Dollar General, L Brands, MGM Resorts, ViacomCBS and Unity Software.
Tuesday's top analyst upgrades and downgrades included Akamai Technologies, Beyond Meat, Broadcom, Dow, Morgan Stanley, Plug Power, TripAdvisor and Zoom Video Communications.
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Cryoport, Inc. provides integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine and cell and gene therapies (CGT).
What is the CYRX stock price target?
The Wall Street consensus 12-month price target for CYRX is $22.33.